LC-MB12

N/A

Report date: 2023/05/29 15:32:29
NME

Base Information

Drug NameLC-MB12
Drug Alias NameLC-MB12LC-MB-12
ClassificationSmall molecules
Mechanisms of ActionFibroblast growth factor receptor 2 degraders
TargetsFibroblast growth factor receptor 2
Therapy Area/IndicationsStomach Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHangzhou Medical College
China Registration ClassN/A

Develop Information

Active CompaniesHangzhou Medical College
Inactive CompaniesN/A
Active IndicationsStomach Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A